BioImpact Equities Fund LP Submits SEC Filing
On March 10, 2026, BioImpact Equities Fund, LP filed a D/A, as recorded in SEC EDGAR documents. The filing pertains to the fund identified by CIK 0001807882.
Details of the Filing
The D/A filing has an accession number of 0000929638-26-000953 and is sized at 9 KB, according to SEC EDGAR. This filing represents a standard submission by the filer, BioImpact Equities Fund, LP.
Filer Background
BioImpact Equities Fund, LP is listed as the filer in the SEC EDGAR system with CIK 0001807882. As is widely known, such entities often engage in regulatory filings to comply with securities laws.
Implications in Context
The filing occurred on March 10, 2026, and includes basic metadata like the accession number, according to SEC EDGAR. As is widely known, SEC filings provide transparency for investment funds, though specifics here are limited to the provided details.
